Researchers detected anti-SARS-CoV-2 IgG antibodies in the blood samples of some pediatric patients prior to viral clearance, according to a study published in The Journal of Pediatrics.

Polytherapy, especially the use of three or more antiepileptic drugs, correlated with a substantially decreased risk for sudden unexpected death in epilepsy, according to findings from a nationwide case-control study conducted in Sweden.

Pain and fatigue levels remain high among patients with ankylosing spondylitis despite apparent disease control with biologic therapies, such as TNF inhibitors, according to a global survey published in the Journal of Clinical Rheumatology.

The results of four randomized, double-masked, vehicle-controlled trials showed KPI-121 0.25% is safe and well tolerated with no unexpected treatment-related adverse events in patients with dry eye disease, according to a study.

Between 2014 and 2018, HIV diagnoses among men who have sex with men (MSM) decreased 2.3% per year overall in the United States, and MSM also experienced improvements in linkage to care and viral suppression, study findings in MMWR showed.

Male sex, high income and self-employment are predictors of faster return to work after total joint arthroplasty, while having a physically demanding job and longer length of stay are linked with slower return to work, according to a study.

After a peritoneal dialysis education program, the number of staff at a Veterans Affairs center who scored their knowledge level on the topic as “high” and “very high” increased, according to presented research.

Treatment with dapagliflozin significantly reduced renal failure, cardiovascular death or hospitalization for heart failure, and prolonged survival among adults with chronic kidney disease with and without type 2 diabetes, study data show.

Prenatal cannabis exposure may increase risk for psychopathology during middle childhood, according to results of a cross-sectional study published in JAMA Psychiatry.

Philips announced that a mechanical thrombectomy system to remove blood clots from vessels within the peripheral arterial and venous systems has received 510(k) clearance from the FDA and is now available in the U.S.